ClinVar Miner

Submissions for variant NM_002230.4(JUP):c.947T>G (p.Val316Gly)

dbSNP: rs1915485566
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genetics and Genomics Program, Sidra Medicine RCV001093565 SCV000999132 uncertain significance Primary dilated cardiomyopathy criteria provided, single submitter research
Invitae RCV001233758 SCV001406367 uncertain significance Naxos disease; Arrhythmogenic right ventricular dysplasia 12 2019-10-19 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with JUP-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces valine with glycine at codon 316 of the JUP protein (p.Val316Gly). The valine residue is highly conserved and there is a moderate physicochemical difference between valine and glycine.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.